Additionally, malignant B-cells can express immunosuppressive ligands (e.g., PD-L1) or secrete molecules (e.g., TGF-β) that recruit regulatory T-cells and tumor-associated macrophages and alter stroma, creating an immune-tolerant microenvironment [33]. Here, TGFB1 is linked to neoplasm.